Bionik Laboratories Corp. engages in the provision of rehabilitation and mobility solutions to individuals with neurological disorders. The company is headquartered in Watertown, Massachusetts and currently employs 12 full-time employees. The company went IPO on 2012-06-12. Its product portfolio includes three InMotion Robots for rehabilitation following stroke and other neurological conditions and four products in varying stages of development. The InMotion robots offer patient-adaptive therapy, intended to restore upper-extremity motor control for a range of neurological conditions and recovery stages, including early recovery from acute stroke. InMotion Robots also provide objective evaluation assessments intended to measure and report the patient’s level of motor impairment and progress during therapy. Its solutions include InMotion Therapy, InMotion ARM, InMotion ARM/HAND, InMotion EVAL, InMotion Connect, InMotion for Physical Therapy, and InMotion for Occupational Therapy. InMotion Robotics provides the occupational therapist with a range of useful protocols designed to reduce many types of upper extremity neurological impairments.
Follow-Up Questions
Who is the CEO of Bionik Laboratories Corp?
Mr. Richard Russo is the President of Bionik Laboratories Corp, joining the firm since 2020.
What is the price performance of BNKL stock?
The current price of BNKL is $0.0001, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Bionik Laboratories Corp?
Bionik Laboratories Corp belongs to Health Care industry and the sector is Health Care
What is Bionik Laboratories Corp market cap?
Bionik Laboratories Corp's current market cap is $1.2K
